title: Self-administration of cocaine and remifentanil by monkeys: choice between single drugs and mixtures.
abstract: BACKGROUND
  Cocaine and opioids are often co-abused. As yet, however, there is no clear evidence that the drugs interact to make the mixture a more effective reinforcer.
  
  
  OBJECTIVE
  The present study examined the relative reinforcing potency and maximum effectiveness of the cocaine-opioid combination in monkeys given a choice between cocaine-opioid mixtures and the single-component drugs.
  
  
  METHODS
  Rhesus monkeys were allowed to choose between injections of cocaine (100 μg/kg/inj) and other doses of cocaine (10-560 μg/kg/inj) or remifentanil (0.03-3.0 μg/kg/inj). A dose-addition model was used to select dose combinations for mixtures of cocaine and remifentanil predicted to be equivalent to 100 μg/kg/inj of cocaine in reinforcing effect if the drugs were additive. The monkeys were then allowed to choose between (a) cocaine and mixtures predicted to be equivalent to 100 μg/kg/inj of cocaine, (b) increasing doses of the mixtures and the single-component drugs, and (c) cocaine or remifentanil at doses that were in the highest safe range.
  
  
  RESULTS
  Generally, monkeys preferred the mixtures over 100 μg/kg/inj of cocaine, evidence for superadditivity. However, preferences for the mixture ceased when relatively high doses of single-component drugs were offered as alternatives. When doses within the mixture were raised and offered with relatively high doses of the single drugs, there was no clear preference for either option. The highest dose of remifentanil was chosen over the highest dose of cocaine by all monkeys.
  
  
  CONCLUSIONS
  The current results indicate that cocaine-opioid combinations can be super-additive in terms of potency, but are not, at maximum, more effective than the single-component drugs.
authors.affiliation: Division of Neurobiology and Behavior Research, Department of Psychiatry and Human Behavior, The University of Mississippi Medical Center, Jackson, MS 39216, USA. kfreeman@psychiatry.umsmed.edu
authors.forename: Kevin B
authors.initials: KB
authors.lastname: Freeman
authors.forename: William L
authors.initials: WL
authors.lastname: Woolverton
mesh_terms: D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D002755:Choice Behavior / Q000187:drug effects*; D003042:Cocaine / Q000008:administration & dosage*; D003216:Conditioning, Operant / Q000187:drug effects; D018765:Dopamine Uptake Inhibitors / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D006993:Hypnotics and Sedatives / Q000008:administration & dosage*; D008253:Macaca mulatta; D008297:Male; D010880:Piperidines / Q000008:administration & dosage*; D012055:Reinforcement Schedule; D000077208:Remifentanil; D012646:Self Administration / Q000379:methods
chemical_list: D018765:Dopamine Uptake Inhibitors; D004338:Drug Combinations; D006993:Hypnotics and Sedatives; D010880:Piperidines; D003042:Cocaine; D000077208:Remifentanil